COMPOSITION CONTAINING REYNOUTRIA JAPONICA EXTRACT OR FRACTION THEREOF FOR PREVENTION AND TREATMENT OF DRY EYE SYNDROME

WIPO Patent Application WO/2018/230942

A1

The present invention relates to a pharmaceutical composition containing a Reynoutria japonica extract or a fraction thereof as an active ingredient for the prevention or treatment of dry eye syndrome, and to a health functional food containing a Reynoutria japonica extract or a fraction thereof as an active ingredient for the prevention or alleviation of dry eye syndrome. The Reynoutria japonica extract or the fraction thereof of the present invention can significantly suppress a reduction in the amount of tears secreted and a change in the shape of cornea, which result from dry eye syndrome, and thus can be widely utilized in the development of a pharmaceutical composition for the prevention or treatment of eye fatigue and dry eye syndrome.

KIM JIN SOOK (KR)
KIM JUNGHYUN (KR)
KIM CHAN-SIK (KR)
KIM YOUNG SOOK (KR)

PCT/KR2018/006659

December 20, 2018

June 12, 2018

Click for automatic bibliography generation  

KOREA INST ORIENTAL MEDICINE (KR)

A61K36/70; A23L33/105

CN102488756A	2012-06-13
KR101108793B1	2012-01-31
KR101764786B1	2017-08-07

SUN, Y. ET AL.: "Quantitative Determination of Resveratrol in Polygonum Cuspidatum and Its Anti-proliferative Effect on Melanoma A375 Cells", BIOMEDICAL RESEARCH, vol. 26, no. 4, 2015, pages 750 - 754, XP055566589
ABENGOZAR-VELA, A. ET AL.: "An in Vivo Study of Anti-inflammatory Effect of Quercetin and Resveratrol Polyphenols in a Desiccating Stress Mouse Model of Dry Eye", ARVO ANNUAL MEETING ABSTRACT, 2014, Retrieved from the Internet

SON, Min (KR)

View/Download PDF      PDF Help

Previous Patent: NETWORK ACCESS METHOD OF TERMINAL, AND METHOD AND APPARATUS FOR MOBILITY SUPPORT AND DATA DELIVERY

Next Patent: IMPROVEMENTS IN AND RELATING TO INTERFERENCE REDUCTION IN DYNAMIC TDD SYSTEMS